Avecho Biotechnology Limited (ASX:AVE)
Dr Paul Gavin
CEO
Market Cap (AUD): 34.89M
Sector: Health Care
Last Trade (AUD):
0.019 +0 (+0%)
Tab Bar
1. About
Avecho Biotechnology Limited (ASX:AVE) is an innovation-led biotechnology company based in Melbourne, Australia.
Avecho develops and commercialises innovative Human Health and Animal Health products, using a proprietary drug delivery system known as Tocopheryl Phosphate Mixture (TPM®).
TPM® is derived from vitamin E using a unique and patented process that enhances the solubility and oral, dermal and transdermal adsorption of drugs and nutrients.